Lingke Wang - 17 Sep 2026 Form 4 Insider Report for Ethos Technologies Inc. (LIFE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Sep 2026, 16:05:21 UTC
Prior SEC filing
21 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Charlie York, Attorney-in-Fact

Key filing fact

Lingke Wang filed Form 4 for Ethos Technologies Inc. (LIFE) on 18 Sep 2026.

Key facts

  • This page summarizes Lingke Wang's Form 4 filing for Ethos Technologies Inc. (LIFE).
  • 5 reported transactions and 9 derivative rows are listed below.
  • Accepted by SEC: 18 Sep 2026, 16:05.

Change

  • Previous filing in this sequence was filed on 21 Aug 2026.
  • Current net transaction value: -$4,610,442.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002089263 Primary reporting owner

Wang Lingke

Relationship
President, Director
Address
C/O ETHOS TECHNOLOGIES INC., 1606 HEADWAY CIRCLE #9013, AUSTIN
Signature
/s/ Charlie York, Attorney-in-Fact
Signature date
18 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LIFE transaction

Class A Common Stock

Conversion of derivative security

Transaction value
Shares
+118,333
Change %
+7.7%
Price
Shares after
1,655,876
Date
17 Sep 2026
Ownership
Direct
Footnotes
F1, F2
LIFE transaction

Class A Common Stock

Sale

Transaction value
$285,053
Shares
-7,431
Change %
-0.45%
Price
$38.36
Shares after
1,648,445
Date
17 Sep 2026
Ownership
Direct
Footnotes
F2, F3, F4
LIFE transaction

Class A Common Stock

Sale

Transaction value
$4,312,893
Shares
-110,587
Change %
-6.7%
Price
$39.00
Shares after
1,537,858
Date
17 Sep 2026
Ownership
Direct
Footnotes
F2, F3, F5
LIFE transaction

Class A Common Stock

Sale

Transaction value
$12,496
Shares
-315
Change %
-0.02%
Price
$39.67
Shares after
1,537,543
Date
17 Sep 2026
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LIFE transaction Derivative

Class B Common Stock

Conversion of derivative security

Transaction value
Shares
-118,333
Change %
-3%
Price
$0.000000*
Shares after
3,811,283
Date
17 Sep 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
118,333
Exercise price
Footnotes
F1
LIFE holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
64,043
Date
17 Sep 2026
Ownership
by spouse
Underlying class
Class A Common Stock
Underlying amount
64,043
Exercise price
Footnotes
F1
LIFE holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
388,726
Date
17 Sep 2026
Ownership
By trust
Underlying class
Class A Common Stock
Underlying amount
388,726
Exercise price
Footnotes
F1, F6
LIFE holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
291,545
Date
17 Sep 2026
Ownership
By trust
Underlying class
Class A Common Stock
Underlying amount
291,545
Exercise price
Footnotes
F1, F7
LIFE holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
291,545
Date
17 Sep 2026
Ownership
By trust
Underlying class
Class A Common Stock
Underlying amount
291,545
Exercise price
Footnotes
F1, F8
LIFE holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
291,545
Date
17 Sep 2026
Ownership
By trust
Underlying class
Class A Common Stock
Underlying amount
291,545
Exercise price
Footnotes
F1, F9
LIFE holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
291,544
Date
17 Sep 2026
Ownership
By trust
Underlying class
Class A Common Stock
Underlying amount
291,544
Exercise price
Footnotes
F1, F10
LIFE holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
291,544
Date
17 Sep 2026
Ownership
By trust
Underlying class
Class A Common Stock
Underlying amount
291,544
Exercise price
Footnotes
F1, F11
LIFE holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
291,544
Date
17 Sep 2026
Ownership
by trust
Underlying class
Class A Common Stock
Underlying amount
291,544
Exercise price
Footnotes
F1, F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 12 footnotes

Footnote F1

Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock. The Class B Common Stock has no expiration.

Footnote F2

Includes shares issuable on settlement of restricted stock units.

Footnote F3

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026, and occurred pursuant to the pre-established terms of such plan rather than as a result of a discretionary decision by the Reporting Person to sell shares at that time.

Footnote F4

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.585 to $38.58 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.605 to $39.55 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

Shares held by The B 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.

Footnote F7

Shares held by The J 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.

Footnote F8

Shares held by The K 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.

Footnote F9

Shares held by The L 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.

Footnote F10

Shares held by The D 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.

Footnote F11

Shares held by The W 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.

Footnote F12

Shares held by The X 2024 Trust. Mr. Wang disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .